Clinical trials: Postviral Syndrome

Covid19, Postviral Syndrome

ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome

• Withdrawn
• Age: 18 to 85 years
• Phase 1/2

This is a Phase I/II trial to evaluate the safety and efficacy of intravenous (IV) administration of bone marrow mesenchymal stem cell derived extracellular vesicles (EV), ExoFlo, as treatment for Post-Acute COVID-19 and Chronic…

Conditions

Covid19, Postviral Syndrome, Dyspnea

Trial name

NCT05116761

Testing

Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles, Saline

Sponsor

Direct Biologics, LLC